Accessed October 2025

Nemluvio®European Medicines Agency. Summary of Product Characteristics. Availableonline. Accessed October 2025

Bewley A, et al. Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments.Dermatol Ther (Heidelb). 2022;12(9):2039–2048. doi: 10.1007/s13555- 022-00782-2

Kwatra SG, Misery L, Clibborn C, Steinhoff M. Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics.Clin Transl Immunology. 2022;11(5):e1390. doi: 10.1002/cti2.1390

Andrade E, et al. Interventions for chronic pruritus of unknown origin.CDSR. 2020;1(1): CD013128. doi: 10.1002/14651858.CD013128.pub2

ClinicalTrials.Gov. Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO) (CPUO). Availableonline. Last accessed October 2025

Gage G, et al. Peripheral blood high-
=*=*=*=*=*=
当前为第8/10页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页